MDXH.F Stock Overview
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
MedX Health Corp Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.035 |
52 Week High | CA$0.06 |
52 Week Low | CA$0.035 |
Beta | 1.18 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -68.18% |
5 Year Change | -67.41% |
Change since IPO | -72.66% |
Recent News & Updates
Recent updates
Shareholder Returns
MDXH.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | -4.1% | -3.5% |
1Y | n/a | 2.2% | 20.2% |
Return vs Industry: Insufficient data to determine how MDXH.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MDXH.F performed against the US Market.
Price Volatility
MDXH.F volatility | |
---|---|
MDXH.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MDXH.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MDXH.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Stephen Lockyer | www.medxhealth.com |
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients’ mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
MedX Health Corp Fundamentals Summary
MDXH.F fundamental statistics | |
---|---|
Market cap | US$11.70m |
Earnings (TTM) | -US$3.99m |
Revenue (TTM) | US$448.64k |
26.1x
P/S Ratio-2.9x
P/E RatioIs MDXH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDXH.F income statement (TTM) | |
---|---|
Revenue | CA$602.57k |
Cost of Revenue | CA$297.72k |
Gross Profit | CA$304.84k |
Other Expenses | CA$5.67m |
Earnings | -CA$5.36m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.02 |
Gross Margin | 50.59% |
Net Profit Margin | -890.28% |
Debt/Equity Ratio | -74.6% |
How did MDXH.F perform over the long term?
See historical performance and comparison